Bit.bio raised $50m in Series C funding round led by M&G Investments.
29 December 2025
29 December 2025
Total investments received (USD): 224.97M
Round value (USD): 50M
Company: bit.bio
Related deals
Immutrin in a £65M series A led by Frazier Life Sciences, joined by SR One, Qiming Venture Partners, Cambridge Enterprise Ventures and F-Prime
Investments
07 March 2026
R1 Therapeutics secured a $77.5 million Series A led by Abingworth, F-Prime Capital and DaVita Venture Group.
Investments
01 March 2026
Chemify in a $50 million equity deal series B Extension backed by Zeon ventures from Japan
Investments
14 February 2026
Tenpoint Therapeutics raises $85M series B with Janus Henderson Investors, Hillhouse Investment, EQT and British Business Bank
Investments
30 January 2026
Orbital Tech raised a $60 million Series B led by Brighton Park Capital, joined by REV (RELX’s VC arm), JLL Spark, Seedcamp, and Grosvenor in the UK
Investments
02 January 2026
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain